Literature DB >> 14506269

Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140.

Kristina A White1, Mark M Yore, Shannon L Warburton, Angelina V Vaseva, Erica Rieder, Sarah J Freemantle, Michael J Spinella.   

Abstract

Nuclear receptor-mediated gene expression is proposed to be regulated by the ordered recruitment of large protein complexes in which activity depends on mutual interactions and posttranslational modifications. In contrast, relatively little attention has been given to mechanisms regulating the expression of the coregulator proteins themselves. Previously we have shown that the ligand-dependent corepressor, RIP140, is a direct transcriptional target of all-trans retinoic acid (RA). Here we demonstrate that RA induction of RIP140 constitutes a rate-limiting step in the regulation of retinoic acid receptor signaling. Silencing of the RA induction of RIP140 dramatically enhances and accelerates retinoid receptor transactivation, endogenous expression of other RA target genes, and RA-induced neuronal differentiation and cell cycle arrest in human embryonal carcinoma cells. The data suggest that RA induction of RIP140 constitutes a functional negative feedback loop that limits activation of retinoid receptors in the continued presence of RA and that acutely regulated expression of coregulators may be a general regulatory mechanism in hormonal signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506269     DOI: 10.1074/jbc.C300374200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Retinoic Acid Induces Ubiquitination-Resistant RIP140/LSD1 Complex to Fine-Tune Pax6 Gene in Neuronal Differentiation.

Authors:  Cheng-Ying Wu; Shawna D Persaud; Li-Na Wei
Journal:  Stem Cells       Date:  2015-10-09       Impact factor: 6.277

2.  PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Authors:  Igor Gurevich; Carmen Zhang; Priscilla C Encarnacao; Charles P Struzynski; Sarah E Livings; Brian J Aneskievich
Journal:  Biochim Biophys Acta       Date:  2011-10-07

3.  Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.

Authors:  Caryl J Giuliano; Sarah J Freemantle; Michael J Spinella
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

Review 4.  Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Authors:  Christina Y Yim; Pingping Mao; Michael J Spinella
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

5.  Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Charles P Struzynsky; Sarah E Livings; Brian J Aneskievich
Journal:  Gene       Date:  2012-12-08       Impact factor: 3.688

6.  Dhrs3a regulates retinoic acid biosynthesis through a feedback inhibition mechanism.

Authors:  L Feng; R E Hernandez; J S Waxman; D Yelon; C B Moens
Journal:  Dev Biol       Date:  2009-10-27       Impact factor: 3.582

7.  The direct p53 target gene, FLJ11259/DRAM, is a member of a novel family of transmembrane proteins.

Authors:  Joanna S Kerley-Hamilton; Aimee M Pike; Justine A Hutchinson; Sarah J Freemantle; Michael J Spinella
Journal:  Biochim Biophys Acta       Date:  2007-02-22

Review 8.  Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.

Authors:  Nina Orfali; Sharon L McKenna; Mary R Cahill; Lorraine J Gudas; Nigel P Mongan
Journal:  Exp Cell Res       Date:  2014-03-30       Impact factor: 3.905

9.  Retinoic acid mediates long-paced oscillations in retinoid receptor activity: evidence for a potential role for RIP140.

Authors:  Kelly C Heim; Joshua J Gamsby; Mary P Hever; Sarah J Freemantle; Jennifer J Loros; Jay C Dunlap; Michael J Spinella
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

10.  Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.

Authors:  Grace E Snow; Allison C Kasper; Alexander M Busch; Elisabeth Schwarz; Katherine E Ewings; Thomas Bee; Michael J Spinella; Ethan Dmitrovsky; Sarah J Freemantle
Journal:  BMC Cancer       Date:  2009-10-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.